内部人交易记录
其他基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Zanganeh Mahkam. Officer active across 2 companies, notably Summit Therapeutics Inc.. Aggregated, 15 disclosures have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €37.7m. Activity tracked since 8 March 2023. The latest transaction was filed on 10 September 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Zanganeh Mahkam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
333,394 股@ US$17.68Common StockSEC:0001599298-25-000143:0
74,545 股@ US$2.640.4% 占其流量Common StockSEC:0001599298-25-000107:0
3,985,055 股@ US$1.5814.2% 占其流量Common StockSEC:0001599298-25-000060:0
30,121 股@ US$11.0046.3% 占其流量Common StockSEC:0001437749-25-003449:0
315,681 股@ US$1.581.1% 占其流量Common StockSEC:0001599298-24-000146:0
44,052 股@ US$22.702.2% 占其流量Common StockSEC:0001599298-24-000141:0
60,242 股Common StockSEC:0001437749-24-022360:0
26,000 股@ US$3.720.2% 占其流量Common StockSEC:0001599298-24-000047:0
489,814 股@ US$1.441.6% 占其流量Common StockSEC:0001599298-23-000103:0
20,000 股@ US$2.145.8% 占其流量Common StockSEC:0001437749-23-032198:0
86,668 股@ US$2.0524.0% 占其流量Common StockSEC:0001437749-23-019535:0
86,668 股@ US$2.0524.0% 占其流量Common StockSEC:0001437749-23-017297:0
16,778,415 股@ US$1.0541.3% 占其流量Common StockSEC:0001387131-23-003381:0
15,973,743 股@ US$1.0539.3% 占其流量Common StockSEC:0001599298-23-000028:0
373,857 股Common StockSEC:0001387131-22-012291:0
About Zanganeh Mahkam
Zanganeh Mahkam is a declarant linked to Summit Therapeutics Inc. and Pulse Biosciences, INC., with 13 filings in total. Across the 13 recent filings we hold, buys amount to EUR 32683908, sells to EUR 0, and the period runs from 2022-12-09 to 2025-04-09.